@article{1c15d8de0d9e4323b053dfe80b1320fc,
title = "EGFR exon 20 insertions in advanced non-small cell lung cancer: A new history begins",
keywords = "EGFR exon 20 insertions, Poziotinib, TAK-788, Amivantamab, Osimertinib, PLUS CETUXIMAB, MOLECULAR CHARACTERISTICS, ACQUIRED-RESISTANCE, 1ST-LINE TREATMENT, OPEN-LABEL, MUTATION, AFATINIB, ADENOCARCINOMA, OSIMERTINIB, POZIOTINIB",
author = "Jordi Remon and Hendriks, {Lizza E. L.} and Cardona, {Andres F.} and Benjamin Besse",
year = "2020",
month = nov,
doi = "10.1016/j.ctrv.2020.102105",
language = "English",
volume = "90",
journal = "Cancer Treatment Reviews",
issn = "0305-7372",
publisher = "ELSEVIER SCI LTD",
}